Latest SELLAS Life Sciences News & Updates

See the latest news and media coverage for SELLAS. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
SELLAS Life Sciences (SELLAS)

Late-stage clinical biopharmaceutical company developing cancer therapies

sellaslifesciences.com
Headquarters
New York, United States
Founded year
2012
Company type
Public company
Number of employees
17–50
Industry
Pharmaceuticals

Last updated

Latest news about SELLAS Life Sciences (SELLAS)

In short: SELLAS reported positive Phase 3 GPS results and proposed a $150 million stock offering.

Company announcements

SELLAS

SELLAS announces proposed $150.0 million underwritten public offering

It intends to grant underwriters a 30-day option for $22.5 million more shares, with J.P. Morgan and TD Cowen as joint book-running managers.

Unlock all announcements with a

Media coverage

The Manila Times

SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Topline Primary Endpoint Results of the Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Following the 80th Event to Report this Month...

Unlock all articles with a

Never miss news about SELLAS

Track SELLAS and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.